PeptiGrowth Inc. and Orizuru Therapeutics, Inc. (Hereinafter, “our company”) have jointly developed synthetic peptides as alternatives to recombinant growth factors used in the manufacturing of regenerative medicine products developed by our company.

Please refer to the press release for details.

◆◆◆◆◆◆

Public Relations, Orizuru Therapeutics, Inc.
Inquiry Form